BRPI0807212A2 - Materiais de íon metálico de poli oxo-hidróxi modificados por ligante, suas utilizações e processos para sua preparação - Google Patents

Materiais de íon metálico de poli oxo-hidróxi modificados por ligante, suas utilizações e processos para sua preparação Download PDF

Info

Publication number
BRPI0807212A2
BRPI0807212A2 BRPI0807212-4A2A BRPI0807212A BRPI0807212A2 BR PI0807212 A2 BRPI0807212 A2 BR PI0807212A2 BR PI0807212 A BRPI0807212 A BR PI0807212A BR PI0807212 A2 BRPI0807212 A2 BR PI0807212A2
Authority
BR
Brazil
Prior art keywords
polyxo
binding
processes
preparation
metal ion
Prior art date
Application number
BRPI0807212-4A2A
Other languages
English (en)
Inventor
Jonathan Joseph Powell
Sylvaine Francoise
Dora Isabel Amaral Pereira
Nuno Jorge Rodrigues Faria
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of BRPI0807212A2 publication Critical patent/BRPI0807212A2/pt
Publication of BRPI0807212B1 publication Critical patent/BRPI0807212B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Catalysts (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0807212-4A 2007-02-06 2008-02-06 Processos para produzir um material sólido de íon metálico de poli oxo-hidróxi modificado por ligante, composições para uso em terapia que compreende o material sólido de íon metálico de poli oxohidróxi modificado por ligante e uso das composições e uso de uma composição compreendendo um material sólido de íon metálico de poli oxo-hidróxi modificado por ligante BRPI0807212B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0702270.0 2007-02-06
US60/888,386 2007-02-06
PCT/GB2008/000408 WO2008096130A1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (2)

Publication Number Publication Date
BRPI0807212A2 true BRPI0807212A2 (pt) 2014-06-17
BRPI0807212B1 BRPI0807212B1 (pt) 2022-01-11

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807212-4A BRPI0807212B1 (pt) 2007-02-06 2008-02-06 Processos para produzir um material sólido de íon metálico de poli oxo-hidróxi modificado por ligante, composições para uso em terapia que compreende o material sólido de íon metálico de poli oxohidróxi modificado por ligante e uso das composições e uso de uma composição compreendendo um material sólido de íon metálico de poli oxo-hidróxi modificado por ligante

Country Status (15)

Country Link
US (1) US8058462B2 (pt)
EP (1) EP2125847B1 (pt)
JP (1) JP5756598B2 (pt)
KR (1) KR101514470B1 (pt)
AU (1) AU2008212653B2 (pt)
BR (1) BRPI0807212B1 (pt)
CA (1) CA2676146C (pt)
CY (1) CY1116590T1 (pt)
EA (1) EA019635B1 (pt)
GB (1) GB2451713B (pt)
HR (1) HRP20150944T1 (pt)
IL (1) IL199901A (pt)
MX (1) MX2009008281A (pt)
PL (1) PL2125847T3 (pt)
WO (1) WO2008096130A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008212653B2 (en) 2007-02-06 2012-05-24 United Kingdom Research And Innovation Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) * 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
JP7033544B2 (ja) 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド 水酸化第一鉄からマルトール第二鉄組成物を生成するための方法
US11267836B2 (en) * 2016-03-31 2022-03-08 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
JP7510254B2 (ja) 2016-08-10 2024-07-03 ユナイテッド キングダム リサーチ アンド イノベーション ナノシリカ粒子を含む組成物および療法のためにｔリンパ球を活性化する方法におけるそれらの使用
CN111050802A (zh) 2017-09-11 2020-04-21 法码科思莫斯控股有限公司 用于治疗用途的铁络合物化合物
GB202005054D0 (en) * 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
US20230338545A1 (en) * 2020-09-17 2023-10-26 Syracuse University Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
AU2022323733A1 (en) 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (pt)
US2575347A (en) 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) * 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
JP4615218B2 (ja) 2001-10-08 2011-01-19 プラク・ビオヘム・ベー・ブイ グルコン酸カルシウムの製造方法
WO2003062140A2 (en) * 2002-01-24 2003-07-31 William Marsh Rice University Organic acid-feooh (ferroxane) particles and ferroxane-derived ceramics and ceramic membranes
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
AU2004317858B2 (en) 2004-03-16 2011-04-21 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
US7179939B2 (en) 2004-03-16 2007-02-20 Navinta Llc Sodium ferric gluconate complexes and method of manufacture thereof
EP2015647A2 (en) 2004-10-08 2009-01-21 Unilever N.V. Iron complex for use in the treatment and/or prevention of nutritional disorders
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
AU2008212653B2 (en) 2007-02-06 2012-05-24 United Kingdom Research And Innovation Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Also Published As

Publication number Publication date
WO2008096130A1 (en) 2008-08-14
JP2010520856A (ja) 2010-06-17
GB0802214D0 (en) 2008-03-12
JP5756598B2 (ja) 2015-07-29
KR101514470B1 (ko) 2015-04-22
HK1138598A1 (en) 2010-08-27
GB2451713B (en) 2009-12-16
HRP20150944T1 (hr) 2015-10-09
AU2008212653B2 (en) 2012-05-24
EP2125847B1 (en) 2015-06-17
CA2676146C (en) 2016-08-09
PL2125847T3 (pl) 2015-12-31
KR20090121281A (ko) 2009-11-25
MX2009008281A (es) 2009-08-25
AU2008212653A1 (en) 2008-08-14
EA200970718A1 (ru) 2010-02-26
CA2676146A1 (en) 2008-08-14
BRPI0807212B1 (pt) 2022-01-11
CY1116590T1 (el) 2017-03-15
US8058462B2 (en) 2011-11-15
GB2451713A (en) 2009-02-11
IL199901A0 (en) 2010-04-15
EA019635B1 (ru) 2014-05-30
EP2125847A1 (en) 2009-12-02
IL199901A (en) 2014-11-30
US20080188555A1 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
BRPI0807212A2 (pt) Materiais de íon metálico de poli oxo-hidróxi modificados por ligante, suas utilizações e processos para sua preparação
IL219268A (en) Anti-b79cd antibody, immunosuppressant and pharmacological agent that includes and uses it
BRPI0816318A2 (pt) Dispositivo de liberação transdérmica, e, método para preparar o mesmo
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0817336A2 (pt) Chapa de antena, transponder e livreto
PL1844337T3 (pl) Związki wiążące, związki immunogenne i peptydomimetyki
BRPI0816683A2 (pt) Maçaneta de segurança para veículos.
DK2077977T3 (da) Vedvarende bindemiddel til ikke-vævet materiale
BRPI1013050A2 (pt) aparelho e mistura para misturar substâncias, e, microchip.
IL188268A0 (en) Transdermal system for varenicline
DK1751066T3 (da) Roterende biologisk kontaktor, som kan konfigureres på forskellig måde
BRPI0811930A2 (pt) Métodos e composições para a identificação e o tratamento de lúpus
BRPI0813227A2 (pt) Máquinas de processamento para redução de material.
BRPI0817778A2 (pt) Fresa laminadora para esmerilhar material de particulado
ZA200905083B (en) Ligand modified poly oxo-hydroxy metal ion materials, thier uses and processes for their preparation
BRPI0718324A2 (pt) Métodos para o tratamento de depressão.
BRPI0913439A2 (pt) composições e métodos para tratar de materiais.
BRPI0819187A2 (pt) Complexo de ácido nucleico e composição para distribuição de ácido nucleico.
AU304929S (en) Razor
DE602006001173D1 (de) Polymere Bindemittel
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
GB0520186D0 (en) Razor
SG128664A1 (en) Filing implement and locking device thereof
BRPI0821002A2 (pt) Compostos e métodos para o tratamento de câncer
ES1061711Y (es) Dispositivo autocentrable para pinza.

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: MEDICAL RESEARCH COUNCIL (GB)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNITED KINGDOM RESEARCH AND INNOVATION (GB)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07G 99/00 , C07F 15/02

Ipc: A61K 33/26 (2006.01), C07F 15/02 (2006.01), C07G 9

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/02/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.